Page last updated: 2024-10-30

metformin and Enlarged Liver

metformin has been researched along with Enlarged Liver in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"There is no known treatment for fatty liver, a ubiquitous cause of chronic liver disease."5.31Metformin reverses fatty liver disease in obese, leptin-deficient mice. ( Chuckaree, C; Diehl, AM; Kuhajda, F; Lin, HZ; Ronnet, G; Yang, SQ, 2000)
"There is no known treatment for fatty liver, a ubiquitous cause of chronic liver disease."1.31Metformin reverses fatty liver disease in obese, leptin-deficient mice. ( Chuckaree, C; Diehl, AM; Kuhajda, F; Lin, HZ; Ronnet, G; Yang, SQ, 2000)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sirtori, CR1
Tremoli, E1
Paoletti, R1
Lin, HZ1
Yang, SQ1
Chuckaree, C1
Kuhajda, F1
Ronnet, G1
Diehl, AM1
Duwoos, H1
Bertrand, CM1
Husson, A1
Cramer, J1
Tayot, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Placebo-controlled, Double-blind Multicenter Phase II Study to Investigate the Protectivity and Efficacy of Metformin Against Steatosis in Combination With FOLFIRI and Cetuximab in Subjects With First-line Palliative Treated, KRAS-Wild-Type,[NCT01523639]Phase 28 participants (Actual)Interventional2012-04-30Terminated (stopped due to Prematurely due to slow recruitment (07/08/2013). Newly defined study end=LPLV=05/11/2013. ABCSG guaranteed completed treatment period for ethical reasons.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for metformin and Enlarged Liver

ArticleYear
New strategies in the development of anti-atherosclerotic drugs.
    Artery, 1980, Volume: 8, Issue:6

    Topics: 4-Aminobenzoic Acid; Animals; Arteriosclerosis; Aspirin; Coronary Disease; Fatty Acids, Nonesterifie

1980

Other Studies

2 other studies available for metformin and Enlarged Liver

ArticleYear
Metformin reverses fatty liver disease in obese, leptin-deficient mice.
    Nature medicine, 2000, Volume: 6, Issue:9

    Topics: Adenosine Triphosphate; Adipose Tissue; Animals; Body Weight; Energy Intake; Energy Metabolism; Fatt

2000
[Reversible hyperlactatemia induced by phenformin with muscular asthenia and cardio-respiratory signs].
    La Presse medicale, 1970, Jan-03, Volume: 78, Issue:1

    Topics: Aged; Animals; Asthenia; Diabetes Complications; Diabetic Ketoacidosis; Dyspnea; Heart Diseases; Hep

1970